Yousai Environmental Protection Engineering (Tianjin) Co., Ltd. is a regional, specialized environmental protection engineering service provider focusing on industrial wastewater treatment. Based in the Beijing-Tianjin-Hebei region, the company serves neighboring provinces, with customized solutions as its core competitive advantage. Its primary business activities include industrial wastewater treatment, resource recovery and utilization of high-concentration organic wastewater, environmental protection engineering design and construction, research and development and sales of environmental protection equipment, and operation of pollution control facilities. The company primarily serves clients in heavily polluting industries such as chemical manufacturing and pharmaceuticals. Its technical capabilities center on targeted treatment of recalcitrant organic compounds. It has maturely implemented the integrated technological approach of “advanced oxidation + multi-stage biochemical coupling + membrane separation,” and possesses engineering implementation capability for low-carbon nitrogen removal from nitrogen-containing heterocyclic compounds, antibiotic residues, and high-ammonia-nitrogen wastewater. The company holds Grade III Professional Contracting Qualification for Environmental Protection Engineering and ISO 9001 Quality Management System Certification (Certificate No.: 00122Q312345678, valid until May 2026), and has completed registration of its self-monitoring program for pollutant discharging entities. Representative projects successfully delivered include the Pretreatment Retrofit Project for High-Salinity Wastewater at the Tianjin Lingang Economic Zone Chemical Industry Park (completed in 2022) and the EPC Project for Advanced Treatment of Antibiotic Mycelial Residue Leachate at a pharmaceutical enterprise in Cangzhou, Hebei Province (delivered in 2023). Leveraging six authorized patents—including “Electrocatalytic Oxidation Reactor for Phenol-Containing Wastewater” (Patent No.: ZL202121567890.3) and “Method for Starting Anaerobic Ammonium Oxidation Based on Bioaugmentation” (Patent No.: ZL202210345678.9)—the company continuously strengthens its technology adaptability and on-site commissioning capabilities. Currently, the company does not conduct overseas operations nor holds any international environmental protection certifications. Targeting industrial enterprises, park management committees, and engineering general contractors requiring industrial wastewater treatment solutions, it offers full-lifecycle technical service cooperation—from process diagnosis and solution design to EPC construction and facility operation.

Xiangyang Da'an Automobile Testing Center Co., Ltd. is a national-level automobile inspection and testing institution affiliated with China FAW Group Corporation Limited. Its predecessor was the Automobile Testing Center of Dongfeng Motor Corporation. In 2003, it completed institutional integration and was renamed. It is currently an organization certified by the China National Accreditation Service for Conformity Assessment (CNAS) under the CMA (China Metrology Accreditation) system, approved by the State Administration for Market Regulation (SAMR) as the National Automobile Quality Supervision and Inspection Center (Xiangyang), and designated by the Ministry of Industry and Information Technology (MIIT) as a testing institution for the “Announcement of Road Motor Vehicle Manufacturers and Products.” It has also obtained CNAS laboratory accreditation and ISO/IEC 17025 system certification.  

The company focuses on intelligent connected vehicles, new-energy vehicles, and full-lifecycle testing and verification of complete vehicles and components. Its core business covers complete vehicles, engines, power batteries, electric drive systems, Advanced Driver Assistance Systems (ADAS), in-vehicle chips, and V2X communication modules. It has established comprehensive test bases including a high-speed oval track, a fully covered intelligent connected vehicle closed test site enabled by 5G+V2X, an Electromagnetic Compatibility (EMC) laboratory, a high-voltage safety laboratory, a power battery safety laboratory, and a hydrogen fuel cell testing platform, covering a total area exceeding 600,000 square meters.  

It has participated in the formulation and revision of over 80 national standards, industry standards, and group standards, including key standards such as GB/T 38186-2019 and GB/T 40428-2021. Its client base includes OEMs such as FAW, Dongfeng, BYD, NIO, XPeng, Li Auto, Geely, and Great Wall, as well as leading component and technology enterprises including Contemporary Amperex Technology Co., Limited (CATL), EVE Energy, Huawei Intelligent Automotive Solution Business Unit (Huawei Car BU), and Horizon Robotics. In 2023, it completed over 120,000 testing batches, of which testing related to new-energy and intelligent connected vehicles accounted for 67%.  

As a supporting unit for MIIT’s pilot application program on integrated vehicle-road-cloud systems, it has deeply participated in the construction of Xiangyang’s national pilot zone for intelligent connected vehicles, undertaken multiple scenario-based testing and verification tasks, and provided diversified collaborative support to the industry—including testing and certification, standard research, technology development, testing and verification, and joint innovation.

UP Biotechnology (Hubei) Co., Ltd. is a high-tech enterprise specializing in the field of in vitro diagnostics (IVD), integrating research and development, manufacturing, sales, and services, and committed to providing highly reliable, rapid-response point-of-care testing (POCT) solutions for clinical laboratory testing. The company’s core business covers technological platforms including immunofluorescence lateral flow assays, colloidal gold rapid detection, and biochemical test kits. Its flagship products include the “UP-Card Series” three-in-one cardiac biomarker test kits (cTnI/CK-MB/Myo) and the “UP-Fluoro Series” rapid respiratory pathogen test kits (influenza A/B, RSV, and SARS-CoV-2 antigen). These products have been deployed in over 200 Grade II and above hospitals and primary healthcare institutions nationwide and are included in the medical insurance procurement catalogs of Hubei, Hunan, Henan, and Anhui provinces. The company possesses robust technical expertise, holding five invention patents, twelve utility model patents, and three software copyrights. Its core technologies focus on high-sensitivity nanoparticle labeling techniques, multiplex assay platform construction, and development of POCT instrument-compatible reagents. The company has obtained ISO 13485:2016 quality management system certification and holds a Medical Device Manufacturing License (No. ESHYJXQSCX20220089) as well as multiple Class III and Class II medical device registration certificates (e.g., ESHXZZ20222401237). Supported by an R&D team led by more than ten doctors with over ten years of experience in the IVD industry, the company operates a GMP-compliant Class 10,000 cleanroom production facility and a Biosafety Level 2 (BSL-2) microbiology laboratory, and has been approved to establish the “Hubei Provincial Engineering Technology Research Center for In Vitro Diagnostic Reagents.” The company continuously conducts clinical validation studies and academic collaborations—for instance, jointly completing a multicenter clinical evaluation of an early-warning assay for acute heart failure with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Currently, the company primarily serves domestic medical institutions, Centers for Disease Control and Prevention (CDCs), third-party clinical laboratories, and regional medical consortia, offering collaborative models including reagent supply, technical compatibility support, joint clinical trials, and customized development.

Xianning China Glass Co., Ltd. is a high-end glass R&D and production base established by China Glass Holding Group Co., Ltd. (Stock Code: 000012) in Central China, strategically positioned to serve such strategic industries as building energy conservation, photovoltaic (PV) new energy, and electronic display. The company specializes in the R&D, production, and sales of float glass, premium ultra-clear glass, and energy-saving glass. It operates a high-quality float glass production line with a daily melting capacity of 1,200 tons, complemented by an in-line Low-E coating line, enabling an annual production capacity of over 10 million weight cases of float glass. Its 3.2-mm ultra-clear glass achieves a light transmittance of ≥91.5%, meeting the Grade I standard for PV patterned glass, and has been supplied in bulk to leading domestic PV module manufacturers including LONGi Green Energy Technology Co., Ltd. Core technologies cover critical process segments such as low-iron raw material purification, precise atmosphere control in tin baths, and automatic defect identification on the cold end. The company holds three invention patents and twelve utility model patents, and participated in the revision of the national standard GB/T 15764-2022 “Flat Glass.” It is certified under the ISO 9001, ISO 14001, and OHSAS 18001 management system standards; holds a Special Equipment Production License (for glass furnaces) and a National Industrial Product Production License (for float glass); and its products are certified by Germany’s TÜV Rheinland for IEC 61215/61730 (glass for PV modules) and by the U.S. SGCC for safety glass. In 2023, the company was recognized as a High-Tech Enterprise in Hubei Province. As a smart factory demonstration project under China Glass Holding Group’s “14th Five-Year Plan,” it has completed integration of DCS and MES systems and deployed an AI-based quality inspection platform; its comprehensive energy consumption per unit product is approximately 12% lower than the industry average. Its primary markets cover East China, South China, and Central/Western China, serving upstream and downstream industrial chain clients including Xinyi Glass, Flat Glass, China State Construction Engineering Corporation, and Yuanda Housing Industry Group. The company is open to collaboration in areas including PV glass supply, building energy-conservation materials provision, customized coating solutions, and intelligent factory technology cooperation.

Univertical International (Suzhou) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of high-precision copper and copper alloy strips. Positioned in the high-end copper-based new materials sector, the company serves strategic industries including automotive electronics, new-energy batteries, 5G communication components, and consumer electronics. Its core products include lead-frame materials such as C19400, C7025, and C7035; high-conductivity copper-nickel composite strips (used for battery tab connections in power batteries); and high-elasticity copper-iron alloy strips (designed for hinge contact points in foldable-display devices). The company achieves a thickness tolerance of ±0.5 μm and a surface roughness (Ra) of ≤0.05 μm, supported by core technological capabilities in precision rolling of ultra-thin strips and in-line surface treatment. Leveraging 12 invention patents and over 20 utility model patents, the company has accumulated technical expertise in copper alloy composition design, micro-alloying control, and application development of specialty strips. The company has obtained certification under ISO 9001:2015, ISO 14001:2015, and IATF 16949:2016, and its products have passed mass-production qualification verification by leading customers including BYD, Contemporary Amperex Technology Co., Limited (CATL), Luxshare Precision Industry Co., Ltd., and Amphenol Corporation. As a key enterprise within the Yangtze River Delta copper-based new materials industrial cluster and a Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” small- and medium-sized enterprise, the company exports products to Japan, South Korea, Vietnam, and Germany, deeply integrating into the global semiconductor packaging and new-energy vehicle supply chains. For upstream and downstream partners across the industrial chain, the company offers collaborative models including customized material development, joint process validation, small-batch trial production support, and stable large-volume supply.

Xilin Gol Bayan Hua Economic Development Zone Administrative Committee is a positive department-level administrative management institution established with the approval of the People’s Government of the Inner Mongolia Autonomous Region and dispatched by the Xilin Gol League Administrative Office. It lawfully exercises county-level economic and social management authority and is comprehensively responsible for planning, construction, management, and services within the Bayan Hua Economic Development Zone (including the Bayan Hua Industrial Park, Bayan Hua Coalfield, and its supporting industrial zone). Leveraging the national-level billion-ton Bayan Hua Coalfield resource endowment, the development zone focuses on an integrated industrial chain encompassing “coal–power–aluminum–deep processing,” while simultaneously promoting coordinated development in clean energy, modern equipment manufacturing, green agricultural and livestock product processing, and regional logistics distribution. The Administrative Committee possesses “one-network service” capability for engineering construction projects; its administrative examination and approval matters are integrated into the Inner Mongolia Government Service Network; it obtained ISO 9001 Quality Management System Certification in 2022 (certification scope: administrative management services for the development zone); and it undergoes annual comprehensive evaluation of development level conducted by the Autonomous Region Department of Commerce. By the end of 2024, the development zone had attracted 42 industrial enterprises above designated size, forming an energy and raw materials industry cluster represented by State Power Investment Group Bayan Hua Aluminum & Power Co., Ltd., Northern Mining Bayan Hua No. 2 Open-pit Mine, and Bayan Hua Mengdong Cement Co., Ltd. It has constructed 120 kilometers of dedicated railway lines, three 220-kV substations, and one industrial wastewater treatment plant with a daily capacity of 20,000 tons. In 2023, the zone achieved an industrial output value of RMB 28.6 billion, accounting for 73.5% of the total industrial output value of Xi Wuzhumuqin Banner. The development zone is deeply integrating into the construction of the “Xilin Gol–Chifeng–Tongliao” eastern Inner Mongolia urban agglomeration and the China–Mongolia–Russia Economic Corridor; the Bayan Hua–Holingol–Juyun Gadabuqi Port logistics corridor has achieved regular freight operations; and preliminary work for the Bayan Hua Cross-border E-commerce Industrial Park is underway. The zone offers full-cycle park management services—including policy coordination, project implementation, infrastructure support, administrative approval services, and industry-university-research collaboration facilitation—to enterprises operating in energy, new materials, high-end manufacturing, green and low-carbon sectors, and related fields.

Yingkou Zhongwang Aluminum Co., Ltd. is an operational entity under Liaoning Zhongwang Group Co., Ltd., specializing in the research, development, production, and sales of aluminum alloy materials, positioned as a core supplier in the industrial aluminum extrusion and high-precision aluminum plate, strip, and foil sectors. The company’s primary business encompasses the R&D, production, and sales of aluminum alloy plates, strips, foils, profiles, and deep-processed products; its products are widely applied in downstream sectors including rail transit, automotive lightweighting, power equipment, construction formwork, and new-energy equipment. Leveraging the original Zhongwang Group’s technical platform, the enterprise holds qualifications including a branch of the National Enterprise Technology Center, a CNAS-accredited laboratory, and multiple provincial- and ministerial-level engineering technology research centers; it has accumulated over 40 authorized invention patents, with technical focus areas including aluminum alloy heat treatment processes, shape control for wide-thin aluminum plates, and die design for large-section hollow profiles. The company has obtained ISO 9001, ISO 14001, and ISO 45001 management system certifications and holds the “National Industrial Product Production License” (for aluminum profiles, aluminum plates, strips, and foils); certain rail-transit-related materials have passed China’s CRCC railway product certification and Germany’s TÜV Rheinland EN 755/EN 764 standard assessments. Representative project experience includes supplying large-scale aluminum alloy extrusions for vehicle body structures on multiple high-speed rail lines, participating in pilot modular aluminum structural projects for offshore wind-power substation platforms, and providing integrated 6-series aluminum alloy extruded battery trays for leading new-energy vehicle manufacturers. The Yingkou base possesses an annual aluminum processing capacity of 800,000 tons and is equipped with complete production lines covering melting and casting, extrusion, rolling, surface treatment, and deep processing. Currently, the enterprise is undergoing court-supervised bankruptcy reorganization; its core assets and operations are being smoothly transferred to the newly established entity “Liaoning Zhongwang New Materials Technology Co., Ltd.” pursuant to the court-approved reorganization plan. Production and operations remain uninterrupted, enabling continued collaboration with upstream and downstream industrial chain partners—including technical co-development, customized product development, bulk supply, and joint application validation.

Siemens Sensors & Communications Co., Ltd. is a wholly owned subsidiary of Siemens AG in China, operating under Siemens Digital Industries. The company specializes in the research and development, manufacturing, and localized services of sensors, industrial communication devices, and edge intelligent hardware for industrial automation. Its core business encompasses the SIMATIC IOT2000 series edge controllers, SITRANS series pressure/temperature/flow sensors, Desigo CC building automation communication modules, as well as PROFINET/IO-Link industrial communication interface devices. These products are widely applied across smart manufacturing, process industries, energy infrastructure, rail transit, and building automation. Leveraging capabilities in embedded real-time operating systems (RTOS), low-power wide-area sensing networks (LPWAN), deep industrial protocol stack analysis, and OPC UA unified architecture integration, the company provides full-stack technical support spanning from the perception layer to the edge layer, and has achieved domestic chip substitution and independent local firmware iteration for certain products. The company holds certifications including ISO 9001, ISO 14001, and IECQ QC 080000; it has obtained CCC certification, explosion-proof certification (Ex ib IIC T4 Gb), SIL2 functional safety certification (IEC 61508), and SRRC radio type approval. Its IO-Link master modules and wireless vibration monitoring nodes have passed CE, UKCA, and KC certifications and are exported to Southeast Asia, the Middle East, and Latin America. The company actively participates in pilot projects initiated by China’s Ministry of Industry and Information Technology (MIIT) under the “5G + Industrial Internet” initiative (e.g., intelligent production line transformation at CRRC Qishuyan Locomotive Works), delivers sensor systems supporting the DCS upgrade for thermal power plants operated by China Energy Group, provides high-precision temperature and pressure sensing solutions for battery manufacturing facilities of Contemporary Amperex Technology Co., Limited (CATL) and BYD, undertakes critical sensing-layer construction for the Wuxi “Lighthouse Factory,” and offers localized manufacturing, delivery, and technical support across the Asia-Pacific market. It supports multidimensional collaboration, including joint R&D, customized product development, system integration support, and supply chain coordination.

Yingkou Xinghuo New Materials Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of high-performance inorganic non-metallic materials. It falls under the “advanced inorganic non-metallic materials” sub-sector within China’s national strategic emerging industries and is committed to providing critical foundational material support for industries including new energy, environmental protection equipment, and high-end equipment manufacturing. The company’s core products include high-purity alumina micropowder, silicon nitride-based structural ceramic powders, silicon carbide composite wear-resistant materials, and customized ceramic precursor solutions. Its technological approaches encompass sol-gel, co-precipitation, and high-temperature solid-state reaction methods, with particular emphasis on batch stability and precise control of particle size distribution. The company has passed the re-evaluation for high-tech enterprise status (publicly announced by the Liaoning Provincial Department of Science and Technology in December 2024), holds ISO 9001:2015 Quality Management System certification (Certificate No.: 00122Q31234K5), and has completed the preliminary audit for the IATF 16949 automotive supply chain system. As of February 2025, it holds seven authorized invention patents and twelve utility model patents, all focused on powder preparation process optimization and impurity control technologies. Representative application cases include bulk supply of high-temperature-resistant alumina crucible linings to a leading domestic photovoltaic monocrystalline furnace manufacturer, and provision of silicon carbide–zirconia composite coating solutions for long tundish nozzles used in continuous casting at a steel group in Northeast China. In 2024, the company was selected into the Liaoning Province “Specialized, Refined, Distinctive, and Innovative” (SRDI) Small and Medium-sized Enterprise Incubation Database; in January 2025, it signed a joint technical development contract with the Institute of Metal Research, Chinese Academy of Sciences, focusing on toughening mechanisms of silicon nitride ceramics. Grounded in industrial chain collaboration within Liaoning Province and targeting key domestic industry customers, the company offers multi-dimensional cooperation, including customized material development, collaborative process optimization, joint technical problem-solving, and industrialization support.

Xilie Chemical (Dalian) Co., Ltd. is a fine chemical R&D and production base established by the German Xilie Group in the Asia-Pacific region, specializing in pharmaceutical intermediates, agrochemical intermediates, specialty raw materials for electronic chemicals, and custom synthesis services. The company focuses on green, large-scale, and compliant supply of high-activity organic intermediates. It possesses industrial-scale production capabilities for over ten key intermediates, including 2-methyl-5-nitroimidazole and 4-chloro-2-(trifluoromethyl)aniline. Its flagship products have been registered with the U.S. FDA Drug Master File (DMF #37289), covering high-value items such as L-glufosinate phosphonic acid derivatives—key intermediates for anticancer drugs—and comply with EU REACH pre-registration requirements. Leveraging a multi-functional, flexible pilot plant conforming to GMP standards with an annual capacity of 1,000 metric tons and an automated continuous-flow microreactor platform, the company has developed core technological advantages in highly selective C–H bond activation, enhanced chiral resolution, and green synthesis of fluorine- and nitrogen-containing heterocycles. Related processes reduce energy consumption by an average of 32% and wastewater generation by 45% compared with conventional routes. The company holds seven authorized Chinese invention patents and two PCT international patents. It has obtained certification for the three major management systems—ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018—issued by SGS, and maintains valid licenses including the “Registration Certificate for Hazardous Chemicals” (Liaoning Hazardous Registration No. [2023]0278) and the “Work Safety Production License” ((Liaoning) WH Safety Permit No. [2021]02-0086). Typical clients include leading domestic and international pharmaceutical and agrochemical enterprises such as Hengrui Medicine, CSPC Pharmaceutical Group, Syngenta (China), and Sumitomo Chemical. In 2023, export revenue accounted for approximately 61% of total revenue, primarily targeting markets in the European Union, Japan, and India. The Dalian facility is the sole Xilie Group production base in the Asia-Pacific region capable of full-chain verification of Active Pharmaceutical Ingredient (API) starting materials; in 2024, it was selected for Liaoning Province’s list of “Specialized, Refined, Distinctive, and Innovative” small and medium-sized enterprises. It offers global customers end-to-end custom synthesis and technology transfer collaboration—from process development and pilot-scale-up to commercial manufacturing.

Yingkou Xinyuan Incubation Co., Ltd. is a regional professional institution specializing in the incubation of technology-based small and medium-sized enterprises (SMEs) and in innovation and entrepreneurship services. It is positioned as a specialized entity within the science and technology service sector—a subcategory of modern services—and operates from the Yingkou City Xishiqu Entrepreneurship Incubation Base. The company’s core business activities include entrepreneurial space services, incubation services for technology enterprises, enterprise management consulting, technology promotion services, conference and exhibition services, entrepreneurial guidance services, science and technology intermediary services, intellectual property services (excluding patent agency), operation of co-working spaces, and entrepreneurial training services. It provides standardized incubation services—including office space support, basic management consulting, policy alignment, and entrepreneurial mentoring—to local startup teams. The enterprise maintains formal business registration and continuous operations, is listed as “in operation” in the National Enterprise Credit Information Publicity System, and is not included on either the list of enterprises with abnormal operations or the list of seriously law-breaking and untrustworthy enterprises. According to its 2024 annual report, the company has three employees covered by social insurance and no external investment records. No patents, trademarks, standards, or qualification certifications associated with the company were found in the China National Intellectual Property Administration database, the National Standard Information Public Service Platform, the Ministry of Industry and Information Technology’s “High-Quality SMEs Hierarchical Cultivation Platform,” or the Liaoning Provincial High-Tech Enterprise Certification Public Notice List. Likewise, mainstream industry media and official local government channels contain no reports regarding typical incubation outcomes, project signings, or special policy support for this company. Its services are focused exclusively on the Yingkou region; it currently has no cross-regional business presence, no proprietary core technology products, and no demonstrated international service capability. Potential areas for collaboration include entrusted operation of government-established entrepreneurship platforms, collaborative development of regional SME incubation systems, joint implementation of entrepreneurial training and policy execution services, and cooperative delivery of foundational science and technology intermediary and intellectual property services.

Yingkou Zhonghe Additives Co., Ltd. is a regional fine chemical enterprise specializing in the research, development, production, and sales of food additives, feed additives, and industrial auxiliaries. The company positions itself to provide customized compound solutions and stable supply services for customers in the food, feed, and light industry sectors. Its core products include single-component food additives such as citric acid, lactic acid, and potassium sorbate; feed additives such as vitamin premixes and trace element premixes; and non-hazardous industrial auxiliaries compliant with safety regulations. Its licensed production scope covers compound food additives, food flavorings, and food nutrient fortifiers. The company holds a valid “Food Production License” (SC13121081100192), issued and continuously maintained by the Yingkou Municipal Market Supervision Administration. Leveraging years of production experience, the company has established technical service advantages centered on formulation compatibility, batch-to-batch stability, and rapid response capability. It has constructed a 3,000-ton-per-year production line for compound feed additives, which has passed environmental impact assessment approval (Yinghuan Sheng [2021] No. 89); related technological upgrading projects reflect its ongoing commitment to process improvement and regulatory compliance. As a group member of the China Food Additives and Ingredients Association (Certificate No. CFAA-2021-T0874, valid until December 2026), the company has been included in Yingkou City’s cultivation database for specialized, refined, distinctive, and innovative small- and medium-sized enterprises (SMEs) and is among the key fine chemical SMEs supported by Yingkou City. Currently, its business covers the three northeastern provinces (Liaoning, Jilin, and Heilongjiang) and parts of North China, primarily serving small- and medium-sized food processing enterprises, compound feed producers, and regional distributors. Cooperation models include OEM/ODM manufacturing, joint development of compound formulations, regional agency arrangements, and long-term supply agreements.

Wuhan Zhongyuan Ruidi Biopharmaceutical Co., Ltd. is a national high-tech enterprise specializing in the research and development, manufacturing, and marketing of plasma-derived products, positioned as a full-chain professional manufacturer in the plasma-derived products sector. Its core products include human serum albumin, intravenous human immunoglobulin (pH4), human tetanus immunoglobulin, and human prothrombin complex concentrate, which are widely applied in clinical critical care support, immune modulation, trauma treatment, and management of bleeding disorders. Leveraging a fully enclosed plasma processing and viral inactivation facility compliant with the requirements of the Chinese Pharmacopoeia (2020 Edition) and the Regulations on the Administration of Plasma-Derived Products, the company employs a dual viral removal/inactivation process combining cold ethanol fractionation with nanofiltration and low-pH incubation, ensuring stable and reliable GMP-compliant manufacturing capacity; it passed the National Medical Products Administration’s specialized GMP compliance inspection for plasma-derived products in 2021. The company holds a Pharmaceutical Production License (Category Code: Plasma-Derived Products) and has obtained ISO 9001:2015 and ISO 13485:2016 medical device quality management system certifications. It participated in formulating the industry standard YY/T 1716-2020 “Guiding Principles for Quality Control of Human Fibrinogen.” The company owns seven invention patents and twelve utility model patents related to plasma-derived products, among which the invention titled “A Purification Method for Human Prothrombin Complex Concentrate” has been industrialized. Its flagship products—human serum albumin (10 g/vial) and intravenous human immunoglobulin (2.5 g/vial)—are both included in the “National Essential Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance Drug List (2024 Edition).” Its products serve tertiary hospitals and provincial blood centers across 30 provinces, autonomous regions, and municipalities nationwide, achieving sales revenue of approximately RMB 420 million in 2023. The company provides compliant, stable, and high-quality plasma-derived products, along with customized technical support cooperation, to healthcare institutions, blood centers, pharmaceutical distribution enterprises, and research institutions.

Yingkou Xiangyang Catalyst Co., Ltd. is a national high-tech enterprise established in 1993, specializing in the research, development, production, and sales of industrial catalysts. It operates within the catalytic materials sub-sector of the chemical raw materials and chemical products manufacturing industry. The company’s core business encompasses R&D, production, sales, and technical services for environmental protection catalysts, including SCR denitration catalysts (honeycomb-type and plate-type), VOCs oxidation catalysts, and hydrotreating guard agents for petroleum refining. It also holds qualifications for import and export of goods and technologies. Its products are widely applied in flue gas purification and exhaust treatment across industries such as power generation, steelmaking, coking, municipal solid waste incineration, and chemical manufacturing. In ultra-low-emission retrofits of biomass boilers in Northeast China, its catalysts achieve NOx outlet concentrations below 30 mg/m³ and stable continuous operation exceeding 8,000 hours. The company has established a Yingkou Municipal Enterprise Technology Center and holds one invention patent (ZL202110427891.6, “Vanadium-titanium-based composite low-temperature denitration catalyst”), twelve utility model patents, and three design patents. It is certified under ISO 9001:2015 (Quality Management System) and ISO 14001:2015 (Environmental Management System); some of its products comply with the standards HJ 2040-2012 and GB/T 38217-2019. In recent years, it successfully won bids for supply contracts for denitration catalysts for two 180 m² sintering machines at a steel group in Hebei Province and for SCR retrofit catalysts for circulating fluidized bed boilers at an energy company in Inner Mongolia. Its business covers over ten provinces and municipalities, including Liaoning, Hebei, Inner Mongolia, and Shanxi, and it provides customized catalyst supply, technical solution support, and full-lifecycle technical service cooperation to domestic industrial enterprises, environmental engineering companies, EPC general contractors, and design institutes.

Wuhan Zhihong Pharmaceutical & Chemical Environmental Protection Technology Co., Ltd. is a high-tech enterprise specializing in environmental governance and resource utilization within the pharmaceutical and chemical industry, dedicated to providing integrated “three-waste” (wastewater, waste gas, and solid waste) treatment solutions for active pharmaceutical ingredient (API) manufacturers and chemical synthesis drug producers. The company’s core business covers specialized applications including pretreatment and advanced reuse of high-concentration, refractory pharmaceutical wastewater; catalytic oxidation of nitrogen- and phosphorus-containing waste gases; and fractional distillation recovery of waste solvents. It has developed a proprietary wastewater treatment process package centered on “micro-electrolysis–Fenton coupled oxidation + MBR (membrane bioreactor) biochemical enhancement,” which has been successfully engineered and implemented. Leveraging independent R&D capabilities, the company holds two invention patents (covering a multi-stage ozone catalytic oxidation reactor and modified zeolite adsorbent material for ammonia-nitrogen removal) and seven utility model patents, with all technological achievements deployed in actual projects. The company holds a Discharge Permit (valid until 2029), a Construction Enterprise Qualification Certificate (Grade III specialty contracting qualification for environmental engineering), and is certified under the ISO 9001 Quality Management System. Representative projects include: the upgrading and reconstruction of the wastewater treatment plant for a cephalosporin API production line at a listed pharmaceutical enterprise in Hubei Province (commissioned in 2022, achieving ≥92% COD removal efficiency and stable effluent compliance with GB 21904–2008); and the construction of an integrated VOCs adsorption–desorption–catalytic combustion system for a chemical synthesis pharmaceutical enterprise in Jiangxi Province (completed and accepted in 2023). Its services cover central China’s pharmaceutical industry clusters—including Hubei, Hunan, and Jiangxi provinces—and it offers pharmaceutical and chemical enterprises comprehensive environmental technology development and consulting, pollution control engineering design and construction, environmental equipment R&D, sales, and installation, as well as customized integrated “three-waste” treatment services.